Page last updated: 2024-11-03

proadifen and Disorders of Sex Development

proadifen has been researched along with Disorders of Sex Development in 1 studies

Proadifen: An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.

Disorders of Sex Development: In gonochoristic organisms, congenital conditions in which development of chromosomal, gonadal, or anatomical sex is atypical. Effects from exposure to abnormal levels of GONADAL HORMONES in the maternal environment, or disruption of the function of those hormones by ENDOCRINE DISRUPTORS are included.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gontovnick, LS1
Bellward, GD1

Other Studies

1 other study available for proadifen and Disorders of Sex Development

ArticleYear
Differential sensitivity of hepatic microsomal aryl hydrocarbon hydroxylase to the inhibitory effect of SKF 525-A in rats of varying age, hormonal- and drug-induced status.
    Canadian journal of physiology and pharmacology, 1982, Volume: 60, Issue:8

    Topics: Age Factors; Animals; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 Enzyme System; Disorders of Se

1982